These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15719829)

  • 1. [Bizarre somatic complaints as a manifestation of schizophrenia].
    Sommer IE; Sierink HD; Bloemkolk D; Selten JP
    Ned Tijdschr Geneeskd; 2005 Jan; 149(5):217-20. PubMed ID: 15719829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interpretations of hallucinations resolution by patient with chronic schizophrenia--case report].
    Murawiec S; Krzystoszek B
    Psychiatr Pol; 2009; 43(2):203-12. PubMed ID: 19697790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current concepts of pharmacological treatment in schizophrenia].
    Jarema M
    Psychiatr Pol; 2002; 36(6):857-68. PubMed ID: 12725017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: a review.
    Schultz SH; North SW; Shields CG
    Am Fam Physician; 2007 Jun; 75(12):1821-9. PubMed ID: 17619525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine use in a patient with chronic schizophrenia and severe parkinsonism.
    Stoner SC; Lea JW; Wolf AL; Berges AA
    Pharmacotherapy; 2005 Nov; 25(11):1651-5. PubMed ID: 16232027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of acupuncture treatment for a patient with severe axial dystonia appearing during treatment for schizophrenia].
    Tani M; Suzuki T; Takada A; Yagyu T; Kinoshita T
    Seishin Shinkeigaku Zasshi; 2005; 107(8):802-10. PubMed ID: 16259404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment.
    Plesnicar BK; Zalar B; Breskvar K; Dolzan V
    J Psychopharmacol; 2006 Nov; 20(6):829-33. PubMed ID: 16478753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychopathology of schizophrenia and brain imaging].
    Gross G; Huber G
    Fortschr Neurol Psychiatr; 2008 May; 76 Suppl 1():S49-56. PubMed ID: 18461545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hashimoto encephalopathy presenting as schizophrenia-like disorder.
    Lin YT; Liao SC
    Cogn Behav Neurol; 2009 Sep; 22(3):197-201. PubMed ID: 19741331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
    Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
    Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Capacity assessment and intervention in 56-yr-old man with schizophrenia.
    Schlechter A
    Mt Sinai J Med; 2008; 75(2):153-5. PubMed ID: 18500718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
    Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
    J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sense of body in schizophrenia].
    Farrer C; Franck N
    Encephale; 2009 Feb; 35(1):43-51. PubMed ID: 19250993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
    Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
    J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness, safety, and tolerability of ziprasidone for treating schizophrenia patients undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Ratner Y; Gibel A; Yorkov V; Ritsner MS
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1401-9. PubMed ID: 17669574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.